Seer Inc (SEER)
1.89
-0.05
(-2.58%)
USD |
NASDAQ |
Mar 28, 16:00
1.885
0.00 (0.00%)
After-Hours: 20:00
Seer Total Liabilities (Quarterly): 39.36M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 39.36M |
September 30, 2023 | 39.17M |
June 30, 2023 | 43.08M |
March 31, 2023 | 39.80M |
December 31, 2022 | 40.94M |
September 30, 2022 | 42.44M |
June 30, 2022 | 44.26M |
March 31, 2022 | 40.63M |
Date | Value |
---|---|
December 31, 2021 | 36.22M |
September 30, 2021 | 12.64M |
June 30, 2021 | 11.00M |
March 31, 2021 | 9.869M |
December 31, 2020 | 10.71M |
September 30, 2020 | 8.354M |
December 31, 2019 | 5.557M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.557M
Minimum
Dec 2019
44.26M
Maximum
Jun 2022
28.27M
Average
39.17M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
CEL-SCI Corp | 16.06M |
AIM ImmunoTech Inc | 5.259M |
IGC Pharma Inc | 2.206M |
NovaBay Pharmaceuticals Inc | 5.815M |
Protalix BioTherapeutics Inc | 50.86M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 436.27M |
Shareholders Equity (Quarterly) | 396.90M |
Current Ratio | 25.00 |